跳转至内容
Merck

1650006

USP

丁卡因 盐酸盐

United States Pharmacopeia (USP) Reference Standard

别名:

4-(丁氨基)-苯甲酸-2-(二甲氨基)乙酯, 丁卡因 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C15H24N2O2 · HCl
CAS号:
分子量:
300.82
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

tetracaine

製造商/商標名

USP

應用

pharmaceutical (small molecule)

格式

neat

SMILES 字串

Cl.CCCCNc1ccc(cc1)C(=O)OCCN(C)C

InChI

1S/C15H24N2O2.ClH/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3;/h6-9,16H,4-5,10-12H2,1-3H3;1H

InChI 密鑰

PPWHTZKZQNXVAE-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Tetracaine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Gel
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Ointment
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Topical Aerosol®
  • Benzocaine, Butamben, and Tetracaine Hydrochloride Topical Solution
  • Lidocaine, Racepinephrine, and Tetracaine Hydrochlorides Compounded Topical Gel
  • Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Ointment
  • Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Topical Powder
眼用局部麻醉药;用于脊髓麻醉

生化/生理作用

阻断 Ca2+ 从肌浆网的电压敏感性释放。

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

法律資訊

Aerosol is a registered trademark of Cytec Technology Corp.

象形圖

Skull and crossbones

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 3 Oral - Eye Irrit. 2 - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Genea Edwards et al.
Biochimie, 105, 99-109 (2014-07-12)
To identify the sphingolipid and ceramide species and their quantitative differences between normotensive and hypertensive intraocular pressure states in DBA/2J mouse aqueous humor (AH). Normotensive and hypertensive AH was sampled from mice by paracentesis. Lipid extraction was performed using modifications
Akihiro Tanaka et al.
Antimicrobial agents and chemotherapy, 58(8), 4380-4383 (2014-05-21)
We have reported significantly higher convulsion prevalence in patients treated with cefepime than in those treated with meropenem. Additionally, cefepime-associated convulsions were found only in patients with brain disorders, not renal failure. Here, we compared the convulsive liability of cefepime
Sara Brittingham et al.
Investigative ophthalmology & visual science, 55(12), 8371-8376 (2014-12-04)
To compare the occurrence rate and depth of the demarcation line and topographical outcome after corneal cross-linking (CXL) for keratoconus using two different treatment protocols. A retrospective analysis of 131 eyes with progressive keratoconus treated with CXL using riboflavin and
Elisa Cinotti et al.
American journal of ophthalmology, 159(2), 324-333 (2014-12-03)
To evaluate whether the handheld in vivo reflectance confocal microscopy that has been recently developed for the study of skin tumors is suitable for the diagnosis of conjunctival tumors. Prospective study, observational case series. We prospectively evaluated the reflectance confocal
Angel Nava-Castañeda et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 31(2), 106-113 (2014-11-05)
The aim of the study was to evaluate the effect of 3 subconjunctival bevacizumab injections in patients with an early corneal pterygium recurrence. This study was a nonrandomized single center trial. Patients with an early corneal pterygium recurrence were selected.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门